Epsiprantel

Epsiprantel (CAS 99158-12-4) is a pyrazinoisoquinoline anthelmintic developed for veterinary use, primarily targeting cestode infections in companion animals. It acts by disrupting calcium ion homeostasis in the parasite’s tegument, leading to paralysis and detachment. The compound is supplied as a high-purity crystalline powder (≥98% by HPLC), suitable for formulation into oral tablets or combination products.

With a favorable safety profile and efficacy against Dipylidium caninum et Taenia species, Epsiprantel is a valuable building block for veterinary pharmaceutical companies. Each batch is accompanied by full analytical documentation, ensuring seamless integration into your quality systems.

Synonymes : Epsiprantel, 99158-12-4, 2-(4-ethyl-1-piperazinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbonitrile, (RS)-2-(4-ethylpiperazin-1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbonitrile

Applications

• Active ingredient in veterinary anthelmintic tablets for dogs and cats
• Combination therapy with other antiparasitics (e.g., praziquantel) for broad-spectrum coverage
• R&D reference standard for analytical method development and stability studies

Quality & Documentation

We supply Epsiprantel with a comprehensive documentation package, including COA, MSDS, and TDS per batch. Each lot is tested for assay, loss on drying, and heavy metals, with results traceable to our quality management system. Stability data can be provided upon request for formulation development.

Packaging & Supply

Standard packaging options are 1 kg, 5 kg, and 25 kg, with custom packing available to suit your production needs. In-stock items ship within 3-5 business days; MOQ is 1 kg. For pricing, samples, and bulk orders, contact our sales team.

Demande de devis

• Notre adresse: 280, rue Main, Xi'an, Shaanxi, Chine
• LyvBio Co. — E-mail : info@lyvbio.com